Takeda Pharmaceutical (TAK) Net Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded Net Margin of 9.28% in the quarter ended Jun 30, 2026, down 1.95 percentage points from 11.23% a year earlier and down 0.91 percentage points from the prior quarter.
Takeda Pharmaceutical (TAK) Net Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Takeda Pharmaceutical's Net Margin came in at 7.84% as of Jun 30, 2026, up 0.81 percentage points year-over-year; for the year ended Mar 31, 2026, it was -3.38%, down 5.74 percentage points from the prior year.
- Annual Net Margin has declined for three straight years, with a five-year change of -15.14 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, Net Margin came in at 2.36% in the year ended Mar 31, 2025 (-1.02 pp), 3.38% in the year ended Mar 31, 2024 (-4.49 pp), 7.87% in the year ended Mar 31, 2023 (+1.43 pp) and 6.45% in the year ended Mar 31, 2022 (-5.31 pp).
- Quarterly Net Margin has ranged from 2.26% in the quarter ended Dec 31, 2024 to 28.52% in the quarter ended Sep 30, 2022 over the past five years.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of +0.04 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 7.21 percentage points in the quarter ended Dec 31, 2025, against a drop of 19.63 percentage points in the quarter ended Sep 30, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 10.19% (quarter ended Mar 31, 2026), 9.47% (quarter ended Dec 31, 2025) and 6.13% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Takeda Pharmaceutical | 2.68 Bn | -23.83 Bn | 5.10 Bn | 9.28% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.28% |
| Mar 31, 2026 | 10.19% |
| Dec 31, 2025 | 9.47% |
| Sep 30, 2025 | 6.13% |
| Jun 30, 2025 | 11.23% |
| Mar 31, 2025 | 10.29% |
| Dec 31, 2024 | 2.26% |
| Sep 30, 2024 | 5.99% |
| Jun 30, 2024 | 7.88% |
| Mar 31, 2024 | 7.89% |
| Dec 31, 2023 | 10.06% |
| Sep 30, 2023 | 8.90% |
| Jun 30, 2023 | 8.44% |
| Mar 31, 2023 | 9.92% |
| Dec 31, 2022 | 10.86% |
| Sep 30, 2022 | 28.52% |
| Jun 30, 2022 | 10.80% |
| Mar 31, 2022 | 14.16% |
| Jun 30, 2021 | 14.50% |
| Mar 31, 2021 | 25.59% |
Takeda Pharmaceutical Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();